Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD

Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD

Background: Oxidative stress is presumed to impair β-adenoceptor function and airway patency. Erdosteine (E), a mucomodulatory compound, has shown important antioxidant properties. Methods: The objective was to assess the effect of antioxidant interventions on short-term airway response to salbutamo...

Full description

Bibliographic Details
Main Authors:	Roberto Dal Negro, Maria Visconti, Fiorenza Trevisan, Stefano Bertacco, Claudio Micheletto, Silvia Tognella
Format:	Article
Language:	English
Published:	SAGE Publishing 2008-10-01
Series:	Therapeutic Advances in Respiratory Disease
Online Access:	https://doi.org/10.1177/1753465808096109

Similar Items

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
by: Calverley PMA, et al.
Published: (2019-12-01)

Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia
by: R.W. Dal Negro, et al.
Published: (2016-01-01)

The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study
by: Roberto Dal Negro, et al.
Published: (2011-04-01)

Comparison of Combined Nebulization of Salbutamol-Ipratropium Bromide with Salbutamol Alone in Children with Mild and Moderate Acute Asthma
by: Naima Fazil Raja, et al.
Published: (2020-09-01)

Efficacy of salbutamol .. ipratropium bromide nebulization compared to salbutamol alone in children with mild to moderate asthma attacks
by: Matahari Harumdini, et al.
Published: (2012-08-01)

Spectrophotometric Determination of Erdosteine at Capsule Dosage Forms
by: Cem ÖNAL, et al.
Published: (2021-03-01)

Randomized controlled trial of erdosteine for acute cough in children with colds
by: Yenny Yenny, et al.
Published: (2011-04-01)

Use of aerosols in bronchiectasis patients
by: R.W. Dal Negro, et al.
Published: (2015-12-01)

Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD
by: De Backer LA, et al.
Published: (2011-11-01)

Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study
by: Roberto Walter Dal Negro, et al.
Published: (2012-04-01)

The relationship between inspiratory lung function parameters and airway hyper-responsiveness in subjects with mild to moderate COPD
by: Ramlal Sunil K, et al.
Published: (2012-04-01)

Fixed drug eruption and anaphylaxis induced concurrently by erdosteine: a case report
by: Da Woon Sim, et al.
Published: (2021-02-01)

Corresponding erdosteine changes autophagy genes expression in hippocampus on Rhinitis medicamentosa model
by: Dokuyucu Recep, et al.
Published: (2015-01-01)

Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD
by: Moretti M, et al.
Published: (2015-10-01)

The role of racemic salbutamol and its stereoisomers on airway responsiveness in vivo
by: Keir, Sandra Dhian
Published: (2001)

Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
by: Beatrix Balint, et al.
Published: (2010-09-01)

The Efficacy of Nebulized Furosemide and Salbutamol Compared with Salbutamol Alone in Reactive Airway Disease: A Double Blind Randomized, Clinical Trial
by: Kambiz Masoumi, et al.
Published: (2014-01-01)

Antioxidant and antiapoptotic effects of erdosteine in a rat model of ovarian ischemia-reperfusion injury
by: Vedat Ugurel, et al.
Published: (2017-01-01)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
by: Dal Negro RW, et al.
Published: (2015-03-01)

Changes in blood hemoglobin and blood gases PaO<sub>2</sub> and PaCO<sub>2</sub> in severe COPD overa three-year telemonitored program of long-term oxygen treatment
by: Dal Negro Roberto W, et al.
Published: (2012-07-01)

Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data
by: Müller V, et al.
Published: (2016-01-01)

Factors associated with exacerbation in mild-to-moderate COPD patients
by: Kim JK, et al.
Published: (2016-06-01)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
by: Johnson KM, et al.
Published: (2018-12-01)

Dose-response curve to salbutamol during acute and chronic treatment with formoterol in COPD
by: La Piana GE, et al.
Published: (2011-07-01)

CLINICAL EFFICIENCY OF VACCINATION, ERDOSTEINE AND PULMONARY REHABILITATION IN THE PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS
by: A. V. Budnevskiy, et al.
Published: (2016-11-01)

Optimizing economic outcomes in the management of COPD
by: Roberto Dal Negro
Published: (2008-03-01)

Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD.
by: Angelo Zinellu, et al.
Published: (2016-01-01)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
by: Laura Miranda de Oliveira Caram, et al.

Small airway bronchodilator response to different doses of salbutamol in 7-year-old children
by: Dong Keon Yon, et al.
Published: (2017-08-01)

Airway inflammation and omega 3 PUFA in mild to moderate asthma
by: Kumar, Aishwarya
Published: (2013)

In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity
by: Soumagne T, et al.
Published: (2020-07-01)

Tidal airway closure in asthma and COPD
by: Claudio Tantucci, et al.
Published: (2016-11-01)

Salbutamol levels in swine body fluids and tissues following feeding of salbutamol
by: 洪明仁
Published: (2001)

Anti-Asthmatic Effects of Saffron Extract and Salbutamol in an Ovalbumin-Induced Airway Model of Allergic Asthma
by: Pranav Nair, et al.
Published: (2021-01-01)

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial
by: F. Maltais, et al.
Published: (2020-10-01)

Effects of salbutamol combined with ulinastatin on respiratory function, inflammation and oxidative stress in COPD patients with laparoscopic surgery
by: Wei He, et al.
Published: (2016-05-01)

The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPD
by: Mahoto Kato, et al.
Published: (2017-12-01)

Asthma and public awareness in Italy: results from CHAOS (Chronic Airway Obstruction Survey)
by: Stefano Uleri, et al.
Published: (2007-06-01)

Effects of salbutamol on the kinetics of sevoflurane and the occurrence of early postoperative pulmonary complications in patients with mild-to-moderate chronic obstructive pulmonary disease: A randomized controlled study.
by: Huayong Jiang, et al.
Published: (2021-01-01)

Does mild COPD affect prognosis in the elderly?
by: Forastiere Francesco, et al.
Published: (2010-06-01)